Application 203576
- Type
- ANDA
- Sponsor
- MYLAN TEORANTA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LEVOLEUCOVORIN CALCIUM | LEVOLEUCOVORIN CALCIUM | SOLUTION;INTRAVENOUS | EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) | No | No |
| 002 | LEVOLEUCOVORIN CALCIUM | LEVOLEUCOVORIN CALCIUM | SOLUTION;INTRAVENOUS | EQ 250MG BASE/25ML (EQ 10MG BASE/ML) | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A203576-001 | LEVOLEUCOVORIN CALCIUM | LEVOLEUCOVORIN CALCIUM | EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) | SOLUTION / INTRAVENOUS | 2015-10-20 | ||
| A203576-002 | LEVOLEUCOVORIN CALCIUM | LEVOLEUCOVORIN CALCIUM | EQ 250MG BASE/25ML (EQ 10MG BASE/ML) | SOLUTION / INTRAVENOUS | 2015-10-20 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A203576-001 | LEVOLEUCOVORIN CALCIUM | EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) | SOLUTION / INTRAVENOUS | 2015-10-20 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A203576-002 | LEVOLEUCOVORIN CALCIUM | EQ 250MG BASE/25ML (EQ 10MG BASE/ML) | SOLUTION / INTRAVENOUS | 2015-10-20 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A203576-001 | LEVOLEUCOVORIN CALCIUM | EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) | SOLUTION / INTRAVENOUS | 2015-10-20 | bb7c543d1eb4… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A203576-002 | LEVOLEUCOVORIN CALCIUM | EQ 250MG BASE/25ML (EQ 10MG BASE/ML) | SOLUTION / INTRAVENOUS | 2015-10-20 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A203576-001 | LEVOLEUCOVORIN CALCIUM | EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) | SOLUTION / INTRAVENOUS | 2015-10-20 | 782e0a99824c… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A203576-002 | LEVOLEUCOVORIN CALCIUM | EQ 250MG BASE/25ML (EQ 10MG BASE/ML) | SOLUTION / INTRAVENOUS | 2015-10-20 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A203576-001 | LEVOLEUCOVORIN CALCIUM | EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) | SOLUTION / INTRAVENOUS | 2015-10-20 | 87673890dc5c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A203576-002 | LEVOLEUCOVORIN CALCIUM | EQ 250MG BASE/25ML (EQ 10MG BASE/ML) | SOLUTION / INTRAVENOUS | 2015-10-20 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A203576-001 | LEVOLEUCOVORIN CALCIUM | EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) | SOLUTION / INTRAVENOUS | 2015-10-20 | 5aa47cf7b7d7… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A203576-002 | LEVOLEUCOVORIN CALCIUM | EQ 250MG BASE/25ML (EQ 10MG BASE/ML) | SOLUTION / INTRAVENOUS | 2015-10-20 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A203576-001 | LEVOLEUCOVORIN CALCIUM | EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) | SOLUTION / INTRAVENOUS | 2015-10-20 | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A203576-002 | LEVOLEUCOVORIN CALCIUM | EQ 250MG BASE/25ML (EQ 10MG BASE/ML) | SOLUTION / INTRAVENOUS | 2015-10-20 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A203576-001 | LEVOLEUCOVORIN CALCIUM | EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) | SOLUTION / INTRAVENOUS | 2015-10-20 | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A203576-002 | LEVOLEUCOVORIN CALCIUM | EQ 250MG BASE/25ML (EQ 10MG BASE/ML) | SOLUTION / INTRAVENOUS | 2015-10-20 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A203576-001 | LEVOLEUCOVORIN CALCIUM | EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) | SOLUTION / INTRAVENOUS | 2015-10-20 | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A203576-002 | LEVOLEUCOVORIN CALCIUM | EQ 250MG BASE/25ML (EQ 10MG BASE/ML) | SOLUTION / INTRAVENOUS | 2015-10-20 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A203576-001 | LEVOLEUCOVORIN CALCIUM | EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) | SOLUTION / INTRAVENOUS | 2015-10-20 | b00525d2431f… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A203576-002 | LEVOLEUCOVORIN CALCIUM | EQ 250MG BASE/25ML (EQ 10MG BASE/ML) | SOLUTION / INTRAVENOUS | 2015-10-20 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A203576-001 | LEVOLEUCOVORIN CALCIUM | EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) | SOLUTION / INTRAVENOUS | AP | 2015-10-20 | ea99ee380514… | |
| 2019-07-19 19:46 UTC | 2019-07 | A203576-002 | LEVOLEUCOVORIN CALCIUM | EQ 250MG BASE/25ML (EQ 10MG BASE/ML) | SOLUTION / INTRAVENOUS | AP | 2015-10-20 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A203576-001 | LEVOLEUCOVORIN CALCIUM | EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) | SOLUTION / INTRAVENOUS | 2015-10-20 | 6a51e52b5d6a… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A203576-002 | LEVOLEUCOVORIN CALCIUM | EQ 250MG BASE/25ML (EQ 10MG BASE/ML) | SOLUTION / INTRAVENOUS | 2015-10-20 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A203576-001 | LEVOLEUCOVORIN CALCIUM | EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) | SOLUTION / INTRAVENOUS | 2015-10-20 | 1c564ffb4f44… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A203576-002 | LEVOLEUCOVORIN CALCIUM | EQ 250MG BASE/25ML (EQ 10MG BASE/ML) | SOLUTION / INTRAVENOUS | 2015-10-20 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A203576-001 | LEVOLEUCOVORIN CALCIUM | EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) | SOLUTION / INTRAVENOUS | 2015-10-20 | ea1830bbd6c7… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A203576-002 | LEVOLEUCOVORIN CALCIUM | EQ 250MG BASE/25ML (EQ 10MG BASE/ML) | SOLUTION / INTRAVENOUS | 2015-10-20 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A203576-001 | LEVOLEUCOVORIN CALCIUM | EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) | SOLUTION / INTRAVENOUS | 2015-10-20 | a72a2bbeb626… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A203576-002 | LEVOLEUCOVORIN CALCIUM | EQ 250MG BASE/25ML (EQ 10MG BASE/ML) | SOLUTION / INTRAVENOUS | 2015-10-20 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A203576-001 | LEVOLEUCOVORIN CALCIUM | EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) | SOLUTION / INTRAVENOUS | 2015-10-20 | 9b2671bbb829… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A203576-002 | LEVOLEUCOVORIN CALCIUM | EQ 250MG BASE/25ML (EQ 10MG BASE/ML) | SOLUTION / INTRAVENOUS | 2015-10-20 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A203576-001 | LEVOLEUCOVORIN CALCIUM | EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) | SOLUTION / INTRAVENOUS | 2015-10-20 | a67488948f0b… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A203576-002 | LEVOLEUCOVORIN CALCIUM | EQ 250MG BASE/25ML (EQ 10MG BASE/ML) | SOLUTION / INTRAVENOUS | 2015-10-20 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A203576-001 | LEVOLEUCOVORIN CALCIUM | EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) | SOLUTION / INTRAVENOUS | 2015-10-20 | 3f0d92c62455… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A203576-002 | LEVOLEUCOVORIN CALCIUM | EQ 250MG BASE/25ML (EQ 10MG BASE/ML) | SOLUTION / INTRAVENOUS | 2015-10-20 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A203576-001 | LEVOLEUCOVORIN CALCIUM | EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) | SOLUTION / INTRAVENOUS | 2015-10-20 | 053a50430f4f… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A203576-002 | LEVOLEUCOVORIN CALCIUM | EQ 250MG BASE/25ML (EQ 10MG BASE/ML) | SOLUTION / INTRAVENOUS | 2015-10-20 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A203576-001 | LEVOLEUCOVORIN CALCIUM | EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) | SOLUTION / INTRAVENOUS | 2015-10-20 | 3bdfa0b2c4d7… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A203576-002 | LEVOLEUCOVORIN CALCIUM | EQ 250MG BASE/25ML (EQ 10MG BASE/ML) | SOLUTION / INTRAVENOUS | 2015-10-20 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A203576-001 | LEVOLEUCOVORIN CALCIUM | EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) | SOLUTION / INTRAVENOUS | 2015-10-20 | 3a93d1ddd44b… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A203576-002 | LEVOLEUCOVORIN CALCIUM | EQ 250MG BASE/25ML (EQ 10MG BASE/ML) | SOLUTION / INTRAVENOUS | 2015-10-20 | 3a93d1ddd44b… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-07-19 19:46 UTC | 2019-07 | A203576-001 | AP | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A203576-002 | AP | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| LEVOLEUCOVORIN CALCIUM | LEVOLEUCOVORIN INJECTION | Slate Run Pharmaceuticals | 124bc214-62f8-40f9-a227-a35e2d1ff2a0 | 2023-08-29 | Warnings, Adverse reactions | LEVOLEUCOVORIN CALCIUM |
| Levoleucovorin | LEVOLEUCOVORIN CALCIUM | Meitheal Pharmaceuticals Inc. | 059a3306-6207-497f-a947-33198f18761f | 2023-08-01 | Warnings, Adverse reactions | LEVOLEUCOVORIN CALCIUM |
| LEVOLEUCOVORIN CALCIUM | LEVOLEUCOVORIN INJECTION | Hainan Poly Pharm. Co., Ltd. | c10b0c18-dd7c-4a76-a79b-b8d38a08ab87 | 2023-05-31 | Warnings, Adverse reactions | LEVOLEUCOVORIN CALCIUM |
| Levoleucovorin | LEVOLEUCOVORIN CALCIUM | Meitheal Pharmaceuticals Inc | b4dd0e14-d42a-4581-b1f0-7ba95b50bca6 | 2022-12-06 | Warnings, Adverse reactions | LEVOLEUCOVORIN CALCIUM |
| Levoleucovorin Calcium | LEVOLEUCOVORIN | Amneal Pharmaceuticals LLC | 0c67eeae-3090-473d-b712-b9a83dc77b72 | 2022-11-07 | Warnings, Adverse reactions | Levoleucovorin Calcium |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
Documents#
| Document | Submission type | Date |
|---|---|---|
| 10238 | ORIG | 2015-10-22 |